insights_auto
Prečo akcie TAK stúpli 3,21%?
Preskúmať podrobnejšiechevron_right
TAK:NYSE
Takeda Pharmaceutical Co Ltd
19,64 USD
arrow_upward
+3,21%(+0,61) 1 d.
15. 10., 13:59:20 GMT-4 · USD
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre TAK…
Otvoriť
19,58 USD
Vysoká
19,89 USD
Nízka
19,45 USD
Trh. kap.
63,88 mld.
Priem. obj.
2,51 mil.
Objem
2,76 mil.
Dividenda
3,21 %
Štvrťročná dividenda
0,16 USD
Prvý obchodný deň po vyplatení dividendy
29. 9. 2026
Max. za 52 týž.
19,89 USD
Min. za 52 týž.
12,99 USD
Výnosy na akciu
-0,33 USD
Beta
-0,06
Akcie v obehu
3,20 mld.
Počet zamestnancov
47 tis.
Otvoriť
19,58 USD
Vysoká
19,89 USD
Nízka
19,45 USD
Trh. kap.
63,88 mld.
Priem. obj.
2,51 mil.
Objem
2,76 mil.
Dividenda
3,21 %
Štvrťročná dividenda
0,16 USD
Prvý obchodný deň po vyplatení dividendy
29. 9. 2026
Max. za 52 týž.
19,89 USD
Min. za 52 týž.
12,99 USD
Výnosy na akciu
-0,33 USD
Beta
-0,06
Akcie v obehu
3,20 mld.
Počet zamestnancov
47 tis.
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
ad-hoc-news.de
·
pred 9 hodinami
Takeda schedules October 29 results call for Takeda stock
TradingView
·
pred 13 hodinami
Takeda Pharmaceutical Company Limited Stock 12‑Month Price Target Raised to $20.74, Implies 9% Upside
Yahoo Finance
·
pred 17 hodinami
Takeda’s ORZEYFUL (oveporexton) Launches Simultaneously in Japan and China Giving Physicians First Access to Prescribe Novel Orexin Agonist to Patients with Narcolepsy Type 1
Stock Traders Daily
·
pred 1 dňom
Trading the Move, Not the Narrative: (TAK) Edition
Profil
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. In 2026, Julie Kim was noted in a news item as "CEO-elect". Wikipedia
Informácie o subjekte Takeda Pharmaceutical Co Ltd
Generálny riaditeľChristophe Weber | Christophe Weber
Zamestnanci47 tis.
Dátum založenia12. 6. 1781
Hlavné sídlo-
Odvetvie-
Webtakeda.com